GENE ONLINE|News &
Opinion
Blog

2025-11-26|

PET/CT Imaging Reveals Multiple Brown Tumors in Thalassemia Patient with Parathyroid Adenoma

by GOAI
Share To

A recent case report has documented the occurrence of multiple brown tumors in a patient with thalassemia, linked to parathyroid adenoma. Researchers examined this rare presentation using PET/CT imaging, shedding light on the complex relationship between thalassemia and parathyroid-related bone metabolism disorders. The findings, detailed by Liu et al., provide insight into how hematological conditions like thalassemia can intersect with endocrine abnormalities to impact skeletal health.

The study focused on the patient’s development of brown tumors, which are non-cancerous lesions resulting from excessive bone resorption due to hyperparathyroidism. In this case, the hyperparathyroidism was caused by a parathyroid adenoma—a benign tumor of the parathyroid gland. Using PET/CT scans, researchers were able to identify and analyze these lesions, offering valuable information about their formation and progression in individuals with underlying hematological disorders such as thalassemia. The report emphasizes the importance of advanced imaging techniques in diagnosing and understanding rare complications associated with systemic diseases.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top